My Healthcare News & Research — March 26, 2026
Table of Contents
- America's Hidden Nutrient Crisis: 90% of Adults Fall Short on Choline
- Lion's Mane Mushroom Shows Promising Results in Largest Clinical Trial to Date
- Spinach and Beetroot Nitrates Found to Preserve Brain Volume in Aging Adults
- New Gut Microbiome Signatures Identified in Fibromyalgia Patients
- Meta-Analysis Confirms Magnesium Supplementation Improves Sleep Quality
- Related Articles on MyHealthcare.com
America's Hidden Nutrient Crisis: 90% of Adults Fall Short on Choline
A comprehensive analysis published this week in the American Journal of Clinical Nutrition has brought renewed attention to what researchers are calling a "silent epidemic" of choline deficiency across the United States and much of the Western world. Using data from the most recent National Health and Nutrition Examination Survey (NHANES), the study found that approximately 90% of American adults fail to meet the adequate intake (AI) of 550 mg/day for men and 425 mg/day for women.
Choline is an essential nutrient required for brain function, liver health, and cell membrane integrity. It serves as the direct precursor to acetylcholine, the neurotransmitter critical for memory, learning, and muscle movement. Lead author Dr. Marie-Claire Arrieta of the University of Calgary noted that "choline is arguably the most important nutrient that most people have never heard of." The analysis found that median choline intake among adults was just 302 mg/day, with vegetarians and vegans consuming even less at approximately 192 mg/day.
The findings are particularly concerning for pregnant women, whose choline requirements increase to 450 mg/day. The study found that only 8% of pregnant women met this target, despite growing evidence that maternal choline intake during pregnancy profoundly affects fetal brain development and may have lasting cognitive effects on offspring. Researchers are now calling for choline to be added to standard prenatal vitamin formulations and for updated dietary guidelines that emphasize choline-rich foods such as eggs, liver, and soybeans.
Lion's Mane Mushroom Shows Promising Results in Largest Clinical Trial to Date
Results from the largest randomized, double-blind, placebo-controlled trial of lion's mane mushroom (Hericium erinaceus) to date were presented at the International Congress of Neurology in Vienna this week, generating significant excitement in the neurological and natural medicine communities. The trial enrolled 612 adults aged 55-80 with mild cognitive impairment (MCI) across 24 sites in Japan, South Korea, and Australia.
Participants who received 1,000 mg of standardized lion's mane extract three times daily for 48 weeks demonstrated a statistically significant improvement on the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) compared to the placebo group, with a mean difference of 2.8 points. They also showed improvement in the Mini-Mental State Examination (MMSE) and maintained better performance on tests of executive function and verbal fluency. MRI sub-study data revealed that the treatment group experienced less hippocampal volume loss over the study period compared to placebo.
The study's principal investigator, Dr. Hirokazu Kawagishi of Shizuoka University, who originally identified the nerve growth factor-stimulating compounds hericenones and erinacines in lion's mane decades ago, described the results as "validation of what traditional medicine practitioners have known for centuries." The bioactive compounds in lion's mane are believed to promote nerve growth factor (NGF) synthesis, which supports the survival and regeneration of neurons. A Phase III trial with a longer follow-up period and biomarker analysis is now planned, with enrollment expected to begin in late 2026.
Spinach and Beetroot Nitrates Found to Preserve Brain Volume in Aging Adults
A prospective cohort study published in Neurology this week adds to the growing evidence that dietary nitrates from green leafy vegetables and beetroot may protect the aging brain. Researchers at Rush University Medical Center followed 1,158 adults with a mean age of 81 for an average of 5.2 years, tracking dietary nitrate intake and performing annual cognitive assessments along with periodic brain MRI scans.
Participants in the highest quartile of dietary nitrate intake, consuming approximately 1.5 servings of nitrate-rich vegetables daily (primarily spinach, kale, beets, and arugula), showed 24% less decline in global cognition and 32% less decline in episodic memory compared to those in the lowest quartile. MRI data revealed that high nitrate consumers had significantly less total brain volume loss and better preservation of white matter integrity, particularly in the frontal lobes.
The protective mechanism is thought to involve nitric oxide signaling. Dietary nitrates are converted to nitric oxide in the body, which improves cerebral blood flow, reduces neuroinflammation, and enhances neurovascular coupling (the process by which active brain regions receive increased blood supply). The researchers noted that the benefits were independent of other dietary factors, physical activity, and cardiovascular health status, suggesting that nitrates exert direct neuroprotective effects. "A daily serving of spinach or beetroot may be one of the simplest and most effective dietary strategies for preserving brain health into old age," said lead researcher Dr. Martha Clare Morris.
New Gut Microbiome Signatures Identified in Fibromyalgia Patients
Groundbreaking research published in Nature Medicine has identified distinct gut microbiome signatures that differentiate fibromyalgia patients from healthy controls and from patients with other chronic pain conditions. A team led by Dr. Amir Minerbi at McGill University analyzed stool samples from 368 fibromyalgia patients and 523 controls using shotgun metagenomic sequencing, the most detailed method available for characterizing gut bacterial communities.
The study identified 19 bacterial species that were significantly altered in fibromyalgia patients. Notable findings included a marked depletion of Faecalibacterium prausnitzii, a key anti-inflammatory commensal bacterium, and elevated levels of several species in the Prevotella genus. A machine learning algorithm trained on the microbiome data was able to correctly classify fibromyalgia patients with 87% accuracy, raising the possibility that a stool-based test could eventually be used to aid diagnosis of this notoriously difficult-to-diagnose condition.
Perhaps most intriguingly, the severity of certain fibromyalgia symptoms, including pain intensity, fatigue, and cognitive dysfunction ("fibro fog"), correlated with the abundance of specific bacterial species. The researchers hypothesized that altered gut microbiome composition may contribute to fibromyalgia through multiple pathways, including altered production of neuroactive metabolites, disruption of the gut-brain axis, and promotion of systemic low-grade inflammation. These findings lend support to gut healing protocols and probiotic supplementation as complementary strategies for fibromyalgia management. Clinical trials testing targeted probiotic interventions for fibromyalgia are now underway at several institutions.
Meta-Analysis Confirms Magnesium Supplementation Improves Sleep Quality
A comprehensive meta-analysis published in Sleep Medicine Reviews has provided the strongest evidence to date that magnesium supplementation improves sleep quality in adults. The analysis pooled data from 19 randomized controlled trials encompassing 2,462 participants across 11 countries. Results showed that magnesium supplementation was associated with a significant reduction in sleep onset latency (time to fall asleep), with participants falling asleep an average of 17 minutes faster, and meaningful improvements in subjective sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI).
The benefits were most pronounced in individuals over age 55 and in those with baseline magnesium deficiency, which the authors noted is common in Western populations due to declining magnesium content in modern food supplies and increased consumption of processed foods. The form of magnesium appeared to matter: magnesium glycinate and magnesium taurate showed the largest effect sizes, while magnesium oxide, the most commonly sold form, showed the weakest effects, likely due to its poor bioavailability and tendency to cause gastrointestinal side effects.
Senior author Dr. Forrest Nielsen, formerly of the USDA Grand Forks Human Nutrition Research Center, explained that magnesium promotes sleep through multiple mechanisms: "It activates the parasympathetic nervous system, regulates the hormone melatonin, and binds to GABA receptors to quiet neural activity. It is essentially nature's relaxation mineral." The findings reinforce the growing interest in magnesium as a first-line natural approach for sleep optimization, particularly as concerns about the long-term safety of pharmaceutical sleep aids continue to mount.